BI 443651

· Boehringer Ingelheim

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for BI 443651, covering 2019-11-27 to 2020-01-02. Get the full timeline:

Most recent: Clinical Trial Update: To Assess Safety, Tolerability and Pharmacokinetics of BI 443651 in Healthy Male Volunteers [Phase 1]